Mirelli Fino

Title: Mirelli Fino: Innovator in Respiratory Syncytial Virus Research

Introduction

Mirelli Fino is a notable inventor based in Stamford, CT (US). He has made significant contributions to the field of virology, particularly in the study of respiratory syncytial virus (RSV). His innovative work has implications for the development of immunogenic compositions that can protect against RSV-related diseases.

Latest Patents

Mirelli Fino holds a patent for a process aimed at increasing RSV surface glycoprotein yields using a mutant strain of RSV. The patent describes a method for producing isolated and purified RSV fusion (F) and attachment (G) glycoproteins in eukaryotic cell cultures infected with the RSV cold-passaged, temperature-sensitive mutant subgroup A2 strain cpts-248/404. This process results in at least a 5-fold increase in F and G protein yields compared to the parent A2 strain. The immunogenic compositions derived from this process can be formulated for in vivo administration to confer protection against RSV-related diseases.

Career Highlights

Mirelli Fino is associated with Wyeth Holdings Corporation, where he has been instrumental in advancing research related to RSV. His work has not only contributed to scientific knowledge but also has practical applications in vaccine development.

Collaborations

Mirelli has collaborated with notable colleagues, including Firelli Alonso-Caplen and Mark William Cutler. These collaborations have further enriched his research and contributed to the advancement of their shared goals in virology.

Conclusion

Mirelli Fino's innovative contributions to RSV research highlight the importance of scientific inquiry in developing effective treatments and vaccines. His work exemplifies the impact of dedicated inventors in the field of medicine.